Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

80
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
80
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

141
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
141
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

320
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
320
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

291
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
291

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Independent and Dose-Dependent Contributions of Clonal Hematopoiesis and Mosaic Loss of Y to Incident Heart Failure.

European journal of heart failure·2026
Same author

Geriatric nutritional risk index associated to long-term prognosis and length of hospitalization in the contemporary transcatheter aortic valve replacement era.

Journal of geriatric cardiology : JGC·2026
Same author

Endothelial ZBTB16: a molecular shield against cardiac aging.

European heart journal·2026
Same author

Atherosclerosis licenses for an exceeding immune response in COVID-19 disease by interferon priming in circulating myeloid cells.

Cardiovascular research·2025
Same author

Relevance of Clonal Hematopoiesis in Immune Cells for Degenerative Aortic Valve Stenosis.

Journal of the American Heart Association·2025
Same author

Clonal hematopoiesis activates procalcific pathways in macrophages and promotes aortic valve stenosis.

The Journal of clinical investigation·2025

相关实验视频

Updated: Jun 26, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.3K

心血管生物标志物的预测价值

Johannes Tobias Neumann1,2,3,4, Raphael Twerenbold1,2,3, Jessica Weimann1,2

  • 1Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

JAMA
|May 13, 2024
PubMed
概括
此摘要是机器生成的。

增加心血管生物标志物,如高灵敏性心脏素I和N终端亲B型尿素,改善了动脉样硬化心血管疾病的预测,特别是老年人心力衰竭和死亡率.

更多相关视频

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.6K
Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.4K

相关实验视频

Last Updated: Jun 26, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.3K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.6K
Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.4K

科学领域:

  • 心脏病学
  • 预防医学
  • 生物标志物研究

背景情况:

  • 识别患有动脉样硬化心血管疾病 (ASCVD) 的高风险个体对于有效的初级预防策略至关重要.
  • 使用已确定的风险因素来评估ASCVD风险,但需要改进风险分层.

研究的目的:

  • 评估常规可用的心血管生物标志物的预后价值,再加上已确定的ASCVD风险因素.
  • 评估ASCVD和相关结果的特定生物标志物的增量预测值.

主要方法:

  • 分析了来自12个国家的28个基于人口的群体的个人数据.
  • 测量了高灵敏度心脏 I,高灵敏度心脏 T,NT-proBNP,BNP和hs-CRP.
  • 使用考克斯回归和重新分类分析评估了与发生的ASCVD,全因死亡率,心力衰竭,缺血性中风和心肌梗塞的相关性.

主要成果:

  • 所有测量的生物标志物与发生的ASCVD和次要结果有显著的关联.
  • 将单个生物标志物添加到已确定的风险因素中改善了风险预测 (C统计).
  • 在65岁以下的个体中,hs- cTnI,NT- proBNP和hs- CRP的组合改善了10年ASCVD预测,对心力衰竭和全因死亡率的改善更大,特别是在65岁以上的个体中.

结论:

  • 心血管生物标志物与心血管事件和死亡率密切相关.
  • 虽然生物标志物在预测ASCVD风险方面提供了适度的改善,但它们的价值在预测心力衰竭和死亡率方面更为重要.
  • 生物标志物的结合增强了风险预测模型,特别是在老年人群和特定的心血管结果中.